基于 6 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Loxam Teri, 董事. Director active across 2 companies, notably Vaxcyte, Inc.. Cumulatively, 11 reports have been logged. Activity tracked since 1 June 2022. The latest transaction was filed on 26 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Teri Loxam is a Board Member at Vaxcyte, Inc. She participates in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. Her experience in the biopharmaceutical sector is an asset for Vaxcyte in achieving its objectives.